Global coalition for adaptive research announces key updates on gbm agile phase 2-3 adaptive platform trial for patients with glioblastoma

Los angeles--(business wire)--global coalition for adaptive research (gcar) announces key updates on gbm agile phase 2-3 adaptive platform trial for patients with glioblastoma.
BHVN Ratings Summary
BHVN Quant Ranking